tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
FibroGen’s Strategic Moves and Clinical Prospects Drive Buy Rating
PremiumRatingsFibroGen’s Strategic Moves and Clinical Prospects Drive Buy Rating
2M ago
FibroGen Sells Subsidiary to AstraZeneca for $220M
Premium
Company Announcements
FibroGen Sells Subsidiary to AstraZeneca for $220M
2M ago
FibroGen completes sale of FibroGen China to AstraZeneca for $220M
Premium
The Fly
FibroGen completes sale of FibroGen China to AstraZeneca for $220M
2M ago
FibroGen’s Strong Financial Position and Promising Clinical Pipeline Drive Buy Rating
PremiumRatingsFibroGen’s Strong Financial Position and Promising Clinical Pipeline Drive Buy Rating
3M ago
FibroGen’s Hold Rating: Balancing Drug Development Progress and Financial Outlook
Premium
Ratings
FibroGen’s Hold Rating: Balancing Drug Development Progress and Financial Outlook
3M ago
FibroGen’s Strategic Moves and Financial Outlook
Premium
Company Announcements
FibroGen’s Strategic Moves and Financial Outlook
3M ago
FibroGen trading halted, news pending
PremiumThe FlyFibroGen trading halted, news pending
5M ago
Upcoming Stock Splits This Week (June 16 to June 20) – Stay Invested
Premium
Market News
Upcoming Stock Splits This Week (June 16 to June 20) – Stay Invested
5M ago
FibroGen Enters New Agreement with HiFiBiO
Premium
Company Announcements
FibroGen Enters New Agreement with HiFiBiO
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100